Observational studyAmerican journal of preventive medicine2025
Role of Cardiovascular Deaths on Changes in the Longevity Gap Between U.S. and Other Countries.
Observational study in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Changes in Life Expectancy After Stroke Among Americans Aged 50 and Above by Sex, 1996-2018.Journal of the American Geriatrics Society · 2026Article
- Insights into US life expectancy stagnation from birth cohort mortality dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Potential and challenges for sustainable progress in human longevity.Nature communications · 2026Article
- Catching up with stagnation: cause-specific dynamics of change in life expectancy at age 65 in the United States, Canada, and Latin America, 2000-2019.The Gerontologist · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionBetween 2008 and 2019 the gap in life expectancy between the U.S. and other high-income countries grew significantly, with the reasons for the growth remaining unknown. This study measured the contribution of cardiovascular disease mortality in the growth of the gap in life expectancy at age 50 years (LE50) between the U.S. and 10 other high-income countries.
methodsCross-sectional observational study in 2008 and 2019, using Human Mortality Database and World Health Organization data for population aged 50 years plus as participants. Actual and counterfactual LE50s were compared to quantify the effect of cardiovascular disease mortality on the growth in the gap. Two counterfactual LE50s were calculated, one based on a cause-deleted method, and another by applying the U.S. trends to other countries. A decomposition was performed to quantify the combined effects of selected death causes and ages.
resultsThe U.S. was the worst-performing country regarding cardiovascular disease mortality improvements between 2008 and 2019. The LE50 gap between the U.S. and the average of the other high-income countries grew 0.33 years for women, explained entirely by cardiovascular disease mortality, and 0.79 years for men, 50% of which was explained by cardiovascular disease mortality. Cardiovascular disease mortality after age 70 years was responsible for 81% of the growth of the gap among women, while for men cardiovascular disease mortality after age 70 years contributed 36%.
conclusionsThe slow rate of decline of cardiovascular disease mortality in the U.S. was the main driver of the growth of the LE50 gap between the U.S. and other high-income countries, so prevention of those deaths is critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.